Publications

Publications

WHO/Victor Garstea
© Credits

Latest publications

All →
Fourteenth meeting of the European Regional Verification Commission for Measles and Rubella Elimination: 15–17 September 2025, Copenhagen, Denmark

The fourteenth meeting of the European Regional Verification Commission for Measles and Rubella Elimination (RVC) took place in Copenhagen, Denmark on...

Strengthening relational continuity in primary care in Spain: key insights and recommended policy actions: primary health care policy paper series

Relational continuity in primary care (RCPC) plays a critical role in health system performance. Extensive evidence demonstrates that strong RCPC is associated...

Report of the thirty-ninth meeting of the European Regional Commission for Certification of Poliomyelitis Eradication: 23–24 September 2025

The thirty-ninth meeting of the European Regional Commission for Certification of Poliomyelitis Eradication (RCC), held on 23–24 September 2025,...

Roadmap for health and well-being in Central Asia 2022–2025: summary evaluation report

The Roadmap for health and well-being in Central Asia 2022–2025 (CARM) was developed to foster joint health initiatives among Kazakhstan, Kyrgyzstan,...



Latest documents

All →

Tuberculosis and malnutrition factsheet

Overview

TB remains an important cause of mortality and morbidity in the WHO European Region and worldwide. Rates of drug-resistant TB are increasing globally. Malnutrition has significant interactions with the TB disease process and may be an important therapeutic target. There is a bidirectional relationship between TB and malnutrition: malnourished individuals are at greater risk of contracting TB, and TB is a catabolic disease that can cause or exacerbate malnutrition. TB patients who are malnourished experience poorer outcomes, which are more pronounced in those with RR/MDR-TB. Malnutrition impairs immune system function in multiple ways, and this may underpin some of the observed relationships. Furthermore, malnutrition can influence how drugs are absorbed and processed, causing treatment failure and downstream effects on treatment toxicity rates in TB patients.

WHO Team
Special Initiative on NCDs and Innovation (SNI)
Number of pages
10